Tower Research Capital (TRC)’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Tower Research Capital (TRC)’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-367	Closed	-$4K	–	6877
2022 Q2	$4K	Buy	367 +68	+23%	+$682	﹤0.01%	5331
2022 Q1	$3K	Sell	299 -1,033	-78%	-$10.3K	﹤0.01%	5490
2021 Q4	$13K	Buy	+1,332	New	+$13.2K	﹤0.01%	4240

Other funds holding SANB

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Tower Research Capital (TRC)'s SANB Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q3 2022, closing a stake of 367 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in SANB in Q4 2021 and held it in 3 quarters. The position peaked at $13K in Q4 2021. 61 funds tracked by Wall St. Rank hold SANB as of Q3 2022.

Tower Research Capital (TRC) reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 367 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q3 2022, an estimated $4K.
Tower Research Capital (TRC) first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 3 quarters.
Tower Research Capital (TRC)'s Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $13K in Q4 2021.
61 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.